Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. More Details
Mediocre balance sheet with moderate growth potential.
Share Price & News
How has Merit Medical Systems's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MMSI has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: MMSI exceeded the US Medical Equipment industry which returned 25.5% over the past year.
Return vs Market: MMSI exceeded the US Market which returned 18.3% over the past year.
Price Volatility Vs. Market
How volatile is Merit Medical Systems's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StShould You Investigate Merit Medical Systems, Inc. (NASDAQ:MMSI) At US$46.40?
2 weeks ago | Simply Wall StCalculating The Intrinsic Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
1 month ago | Simply Wall StWe're Watching These Trends At Merit Medical Systems (NASDAQ:MMSI)
Is Merit Medical Systems undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: MMSI ($48.98) is trading above our estimate of fair value ($35.21)
Significantly Below Fair Value: MMSI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MMSI is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: MMSI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MMSI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MMSI is good value based on its PB Ratio (2.9x) compared to the US Medical Equipment industry average (4.1x).
How is Merit Medical Systems forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MMSI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: MMSI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: MMSI's is expected to become profitable in the next 3 years.
Revenue vs Market: MMSI's revenue (7.7% per year) is forecast to grow slower than the US market (9.9% per year).
High Growth Revenue: MMSI's revenue (7.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MMSI's Return on Equity is forecast to be low in 3 years time (8.2%).
How has Merit Medical Systems performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MMSI is currently unprofitable.
Growing Profit Margin: MMSI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: MMSI is unprofitable, and losses have increased over the past 5 years at a rate of 14.9% per year.
Accelerating Growth: Unable to compare MMSI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MMSI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.9%).
Return on Equity
High ROE: MMSI has a negative Return on Equity (-3.21%), as it is currently unprofitable.
How is Merit Medical Systems's financial position?
Financial Position Analysis
Short Term Liabilities: MMSI's short term assets ($445.9M) exceed its short term liabilities ($174.2M).
Long Term Liabilities: MMSI's short term assets ($445.9M) do not cover its long term liabilities ($612.8M).
Debt to Equity History and Analysis
Debt Level: MMSI's debt to equity ratio (44.8%) is considered high.
Reducing Debt: MMSI's debt to equity ratio has reduced from 46.3% to 44.8% over the past 5 years.
Debt Coverage: MMSI's debt is well covered by operating cash flow (27.7%).
Interest Coverage: MMSI is unprofitable, therefore interest payments are not well covered by earnings.
What is Merit Medical Systems's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MMSI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MMSI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MMSI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MMSI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MMSI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Fred Lampropoulos (70 yo)
Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. Mr. Lampropoulos serves as the Chairman and Chief Executive Officer of Merit Medical Systems Inc. He has bee ...
CEO Compensation Analysis
Compensation vs Market: Fred's total compensation ($USD5.05M) is about average for companies of similar size in the US market ($USD5.61M).
Compensation vs Earnings: Fred's compensation has increased whilst the company is unprofitable.
|CFO & Treasurer||2.42yrs||US$1.17m||0.0053% |
|Chief Operating Officer||6.75yrs||US$1.23m||0.038% |
|Executive Vice President of Commercial||2.17yrs||US$1.21m||0% |
|President of International Division||5.25yrs||US$1.47m||0.018% |
|Chief Technology Officer||no data||no data||no data|
|Chief Information Officer||14.75yrs||no data||no data|
|Chief Legal Officer & Corporate Secretary||4.5yrs||US$1.20m||0.00021% |
|Vice President of Corporate Communications||no data||no data||no data|
|Chief Regulatory Affairs Officer||7.75yrs||no data||no data|
|Chief Wellness Officer||1.25yrs||no data||no data|
|President of Merit Endotek||no data||US$217.25k||no data|
Experienced Management: MMSI's management team is seasoned and experienced (5.3 years average tenure).
|Lead Independent Director||no data||US$329.90k||0.034% |
|Independent Director||0.33yr||no data||no data|
|Independent Director||0.33yr||no data||0.0029% |
|Independent Director||5.25yrs||US$329.90k||0.020% |
|Independent Director||3.42yrs||US$329.90k||0% |
|Independent Director||0.33yr||no data||0.00067% |
|Independent Director||1.17yrs||US$187.15k||no data|
Experienced Board: MMSI's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: MMSI insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Merit Medical Systems, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Merit Medical Systems, Inc.
- Ticker: MMSI
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$2.718b
- Shares outstanding: 55.48m
- Website: https://www.merit.com
Number of Employees
- Merit Medical Systems, Inc.
- 1600 West Merit Parkway
- South Jordan
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MMSI||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||May 1990|
|MM3||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||May 1990|
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/25 23:59|
|End of Day Share Price||2020/10/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.